Monday, September 14, 2026

Hyundai’s EV Domination Continues—Here’s Why the IONIQs Are Winning Big

Hyundai's IONIQ 5, IONIQ 6, and Tucson Hybrid win 2025 Best Hybrid and Electric Cars Awards, excelling in performance and efficiency.

How Dae Hong Dan Corn Could Solve North Korea’s Food Crisis: A Deep Dive into Hybrid Agriculture

Dr. Kim Soon-kwon develops corn varieties for North Korea, aiming to combat food shortages and promote agricultural cooperation.

Samsung Electronics at the 2026 Winter Olympics: Inside the IOC Gala Where JD Vance and Global CEOs Converged

Lee Jae Yong of Samsung Electronics engages in sports diplomacy at the 2026 Winter Olympics, enhancing global ties and brand visibility.

Tag: Samsung Biologics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

Samsung Biologics Earns EcoVadis Platinum: What Joining the Top 1% Signals for Global Pharma Supply Chains

Samsung Biologics achieves Platinum rating from EcoVadis, recognizing its top-tier ESG performance in sustainability and corporate responsibility.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Global Pharma Giants Join Samsung Biologics in Major Climate Pledge to Cut Supply-Chain Emissions by 2030

Samsung Biologics leads a global initiative to reduce carbon emissions in healthcare, aiming for sustainability and renewable energy by 2030.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Samsung Biologics Targets Japan’s $12.3 Billion CDMO Market: What You Need to Know

Samsung Biologics expands in Japan, targeting top pharma firms with new CMO brand 'ExellenS' and enhancing production capabilities.

Samsung Launches New Mini-Organ Tech to Speed Up Cancer Drug Testing

Samsung Biologics launches Samsung Organoids for drug screening, focusing on anticancer candidates to enhance precision and reduce costs.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.